Evidence map›Paper›PMID 38611114›Full record

ArticleCancers2024

Clinical [

Amy R Sharkey, Norman Koglin, Erik S Mittra, Sangwon Han, Gary J R Cook, Timothy H Witney

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Imaging the hallmarks of cancer.Nature reviews. Cancer · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Compact and cGMP-compliant automated synthesis of [EJNMMI radiopharmacy and chemistry · 2025
    Article
  7. Review
  8. [Npj imaging · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

Amy R SharkeySchool of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, UK.ORCID 0000-0002-0916-9123
Norman KoglinLife Molecular Imaging, 13353 Berlin, Germany.
Erik S MittraDivision of Molecular Imaging and Therapy, Oregon Health & Science University, Portland, OR 97239, USA.
Sangwon HanDepartment of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.ORCID 0000-0001-8095-0396
Gary J R CookSchool of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, UK.ORCID 0000-0002-8732-8134
Timothy H WitneySchool of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, UK.ORCID 0000-0002-9475-2873
King's College London · GBInstitute of Molecular Biology · DEOregon Health & Science University · USSt Thomas' Hospital · GBUlsan College · KR

Funding

Cancer Research UK C1519/A28682Wellcome Trust 220221Wellcome Trust 220221/Z/20/ZWellcome Trust WT 203148/Z/16/Z
6 · The paper itself

Abstract

background(4

methodsThis retrospective analysis of prospectively collected data compared [

resultsThe mean administered activity of [

conclusion[

Indexed as

[18F]FSPGheterogeneityHNSCCNSCLCredox

Identifiers

PMID38611114
PMCPMC11011143
OpenAlexW4394576297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.